Virtu Financial »

Inhibikase Therapeutics shares owned by Virtu Financial

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Virtu Financial from 13F filings

Historical chart of Virtu Financial investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Virtu Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Virtu Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $22k 13k 1.64

More positions owned by Virtu Financial

Erkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
UnitedHealth (UNH)
Iberty Media Corp Del Com Lbty Liv S A (LLYVA)
Ox Corp Cl B Com (FOX)
Microsoft Corporation (MSFT)
Pplovin Corp Com Cl A (APP)
Illow Group Cl A (ZG)
Uscale Pwr Corp Cl A Com (SMR)
Anguard Index Fds S P 500 Etf Shs (VOO)
D-wave Quantum (QBTS)
Broadcom (AVGO)
Apple (AAPL)
Eta Platforms Cl A (META)
Itwise Bitcoin Etf Tr Shs Ben Int (BITB)

View all positions for Virtu Financial

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Fairmount Funds Management
Perceptive Advisors
Commodore Capital
ADAR1 Capital Management
Vanguard Group
BlackRock
Blackstone Group
Nantahala Capital Management
Geode Capital Management
Stonepine Capital Management
State Street Corporation
Northern Trust
William Blair $ Company

View all funds holding Inhibikase Therapeutics